Insulet Corporation - Common Stock (PODD)

209.84
+1.83 (0.88%)
NASDAQ · Last Trade: Mar 31st, 5:13 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close208.01
Open210.81
Bid202.60
Ask218.00
Day's Range206.55 - 212.92
52 Week Range205.11 - 354.88
Volume751,486
Market Cap14.45B
PE Ratio (TTM)60.13
EPS (TTM)3.5
Dividend & YieldN/A (N/A)
1 Month Average Volume986,980

Chart

About Insulet Corporation - Common Stock (PODD)

Insulet Corp is a healthcare company specializing in the development and manufacturing of innovative insulin delivery systems for individuals with diabetes. The company is best known for its Omnipod Insulin Management System, a tubeless, waterproof device that allows users to deliver insulin discreetly and conveniently without the need for traditional syringes or infusion sets. Insulet is committed to enhancing the quality of life for diabetes patients by providing advanced technology solutions that simplify insulin management, improve glycemic control, and promote independence in self-care. Through ongoing research and development, Insulet aims to lead the way in diabetes management innovation. Read More

News & Press Releases

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · March 31, 2026
What's going on in today's pre-market session: S&P500 moverschartmill.com
Via Chartmill · March 31, 2026
Winners And Losers Of Q4: Insulet (NASDAQ:PODD) Vs The Rest Of The Patient Monitoring Stocks
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the patient monitoring stocks, including Insulet (NASDAQ:PODD) and its peers. Patient m...
Via StockStory · March 30, 2026
Insulet Appoints Mike Panos as Chief Commercial Officer
Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the appointment of Mike Panos as Executive Vice President, Chief Commercial Officer, effective immediately. In this role, Mr. Panos will lead Insulet’s global commercial organization, reporting to President and Chief Executive Officer Ashley McEvoy. He will also be a member of the Executive Leadership Team.
By Insulet Corporation · Via Business Wire · March 30, 2026
Discover the top S&P500 movers in Thursday's after-hours session.chartmill.com
Via Chartmill · March 12, 2026
PODD Investors Have Opportunity to Join Insulet Corporation Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Insulet Corporation (“Insulet” or “the Company”) (NASDAQ: PODD) for violations of the securities laws.
By The Schall Law Firm · Via Business Wire · March 28, 2026
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...
Via StockStory · March 27, 2026
3 S&P 500 Stocks for Long-Term Investors
The S&P 500 (^GSPC) is full of established businesses, but only some continue to outperform the market. A few standout companies are thriving thanks to stron...
Via StockStory · March 27, 2026
Stay informed with the top movers within the S&P500 index on Wednesday.chartmill.com
Via Chartmill · March 25, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · March 24, 2026
Securities Fraud Investigation Into Insulet Corporation (PODD) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) investors concerning the Company’s possible violations of the federal securities laws.
Securities Fraud Investigation Into Insulet Corporation (PODD) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz continues its investigation of Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) on behalf of investors concerning the Company’s possible violations of federal securities laws.
By Law Offices of Frank R. Cruz · Via Business Wire · March 18, 2026
Insulet Corporation (PODD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith continues its investigation on behalf of Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) investors concerning the Company’s possible violations of federal securities laws.
By Law Offices of Howard G. Smith · Via Business Wire · March 18, 2026
1 Healthcare Stock with Exciting Potential and 2 We Avoid
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva...
Via StockStory · March 18, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · March 17, 2026
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investmentfool.com
EyePoint develops sustained-release treatments for retinal diseases, leveraging proprietary technology and strategic industry partnerships.
Via The Motley Fool · March 15, 2026
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcementfool.com
This medical technology firm delivers advanced noninvasive monitoring and automation solutions to healthcare providers worldwide.
Via The Motley Fool · March 15, 2026
EXCLUSIVE: Just 5 Female CEOs In A 50-Stock ETF — C-Suite Execs Explain The Leadership Gap In Corporate Americabenzinga.com
-link data-ticker=GOOGL data-exchange=NASDAQ href=https://www.benzinga.com/quote/GOOGL target=_blank rel=noopener>(NASDAQ: GOOGL), One week after we celebrated the International Women's day, here is a stark reminder how the C-suite remains underrepresented by women.Data from a leadership-focused ETF underscores how uncommon female leadership remains among large U.S. companies. The Wedbush ReturnOnLeadership U.S. Large-Cap ETF (ARCA: EXEQ) universe of 50 companies, only about 10% are led by women CEOs. Those include Jayshree Ullal of Arista Networks Inc (NYSE: ANET), Lori Koch of DuPont de Nemours Inc (NYSE: DD), Martina Cheung of S&P Global Inc (NYSE: SPGI), Ashley McEvoy of Insulet Corp (NASDAQ: PODD) and Debra Cafaro of Ventas Inc (NYSE: VTR). The ETF tracks companies ranked through a leadership execution framework developed by Indiggo. Janeen Gelbart, co-founder and CEO of the firm, said the methodology evaluates corporate leadership broadly rather than focusing on individual executives.
Via Benzinga · March 14, 2026
Securities Fraud Investigation Into Insulet Corporation (PODD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) investors concerning the Company’s possible violations of the federal securities laws.
Insulet Corporation (PODD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) investors concerning the Company’s possible violations of federal securities laws.
By Law Offices of Howard G. Smith · Via Business Wire · March 13, 2026
Exploring the top movers within the S&P500 index during today's session.chartmill.com
Via Chartmill · March 13, 2026
Securities Fraud Investigation Into Insulet Corporation (PODD) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) on behalf of investors concerning the Company’s possible violations of federal securities laws.
Friday's session: top gainers and losers in the S&P500 indexchartmill.com
Via Chartmill · March 13, 2026
Friday's session: gap up and gap down stock in the S&P500 indexchartmill.com
Via Chartmill · March 13, 2026
Top S&P500 movers in Friday's pre-market sessionchartmill.com
Via Chartmill · March 13, 2026